PMCPA
Digital Pharma: Twitter slip-up shouldn’t silence pharma
September 9, 2011Medical Communications, Sales and Marketing Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter
Bayer UK was recently ruled to have breached the ABPI Code of Practice by promoting prescription-only medicines to the general …
Digital Pharma: Bayer reprimanded over social media use
August 17, 2011Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA
Bayer will be named in the medical press after being found guilty of the first social media breach of the …
Digital Pharma: Bayer tweets breach ABPI Code of Practice
July 5, 2011Medical Communications Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter, medical communications news, social media
Bayer’s use of Twitter has caused the first social media breach of the ABPI Code of Practice. Code regulator the …
Digital Pharma: Bayer UK’s Twitter slip-up
April 26, 2011Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA, Twitter, medicial communications
There seems to be some confusion at Bayer UK over what communications can be sent over Twitter. The company is …
Digital Pharma: UK gets social media guidance
April 5, 2011Medical Communications Code of Practice, Digital Pharma blog, PMCPA, digital marketing
The UK’s Code of Practice regulator has issued guidance on social media and other digital communications tools. It is the …
Allergan marketing breaches discredited industry
March 22, 2011Medical Communications Allergan, Cephalon, PMCPA
Allergan, the manufacturer of Botox, has been censured for several breaches of the ABPI Code of Practice. The PMCPA watchdog …
Cephalon in trouble over party spirit
February 11, 2011Medical Communications ABPI, ABPI Code of Practice, Cephalon, PMCPA, industry reputation
Cephalon has been criticised by UK authorities for bankrolling “excessive” hospitality at a conference in Lisbon.The company was cited by …
Boehringer’s Pradaxa advertising breaches Code
January 21, 2011Medical Communications ABPI, Bayer Schering Pharma, Boehringer Ingelheim, Code of Practice, PMCPA, Sanofi-Aventis
Boehringer Ingelheim has fallen foul of the ABPI Code of Practice on five counts in a row over an advertisement …
Novo rebuked after diabetes promotion breaches Code
December 16, 2010Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly
Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …
Daiichi-Sankyo cleared of rep misconduct
November 22, 2010Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Daiichi Sankyo, Daiichi-Sankyo, Olmetec, PMCPA, olmesartan, pharma sales representative
Daiichi-Sankyo has been cleared of any wrongdoing in relation to the ABPI Code after one of its representatives was accused …
New ABPI Code published
November 17, 2010Medical Communications, Sales and Marketing 2011 ABPI Code, ABPI, ABPI Code of Practice, PMCPA, pharma marketing, pharma sales
The ABPI has published the 2011 version of its Code of Practice for UK pharmaceutical companies, with copies now available …
Bayer faces ABPI audit after “shocking” Levitra error
November 5, 2010Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Bayer, PMCPA
Bayer has been accused of a “shocking error of judgement” after promotional material for its erectile dysfunction brand Levitra (vardenafil) …
Digital Pharma: Pfizer, Enbrel and UK Google Adwords
October 22, 2010Medical Communications ABPI Code of Practice, Digital Pharma blog, Enbrel, Google Adwards, PMCPA, Pfizer, pharma SEO
Pfizer is using Google Adwords in the UK to promote an online eCongress for healthcare professionals interested in its arthritis …
GSK cleared of unethical practices by PMCPA
October 22, 2010Medical Communications ABPI, ABPI Code of Practice, Avamys, GSK, GlaxoSmithKline, PMCPA, Rupafin, Seretide
GlaxoSmithKline has been found guilty of two transgressions of the ABPI Code of Practice in a case centring on the …
Grünenthal breaches Code with off-label promotion
September 28, 2010Medical Communications Code of Practice, Grunenthal, PMCPA, Versatis
Grünenthal has been severely criticised in two rulings by UK pharma’s self-regulatory body the PMCPA for promoting off-label use of …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
